A dual-fluorescence high-throughput cell line system for probing multidrug resistance. - Wikidata - wikimedia - TriplyDB

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

http://www.wikidata.org/entity/Q33472881

about

Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier Inhibition of glutathione peroxidase mediates the collateral sensitivity of multidrug-resistant cells to tiopronin Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform.A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cells.Modeling intrinsic heterogeneity and growth of cancer cells.Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL.The Inhibitor Ko143 Is Not Specific for ABCG2 The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2).Cell-based high-throughput screens for the discovery of chemotherapeutic agents.Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein.MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.The impact of cell density and mutations in a model of multidrug resistance in solid tumors.Microfabricated polymeric vessel mimetics for 3-D cancer cell culture Overlapping substrate and inhibitor specificity of human and murine ABCG2.Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?Modeling the Transfer of Drug Resistance in Solid Tumors.Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining.Cytotoxicity Test Based on Human Cells Labeled with Fluorescent Proteins: Fluorimetry, Photography, and Scanning for High-Throughput Assay.Stably Fluorescent Cell Line of Human Ovarian Epithelial Cancer Cells SK-OV-3ip-red.

P2860

Q27684429-4E0970FE-DD82-406D-95E5-8491D34D50A5 Q33891067-E0F6D25B-A263-4460-B07F-831D720BD553 Q33985320-9467506B-EBDE-417D-829E-BA66D8258D90 Q33991690-B61AD745-537D-4243-9637-49DFB49CF561 Q34367618-D40DFD3F-D74A-4B4E-A6B4-D9CD3CA38D97 Q34977187-2E351553-DBFA-4845-8276-AAFF4C08AE73 Q35019882-2E2F5844-ADE4-4A88-A443-9EFFAA2122E5 Q35051303-8992F39F-7DD2-465E-8E8F-765962BE8092 Q35447223-59EA0A11-7648-4734-8343-9BB978801D1E Q35528557-ACBD16AB-362B-4AC4-AF86-80BCB421B661 Q35744147-424F1700-4E6A-429F-BF10-F7F991DCB021 Q35909089-B0751CB8-EAFE-4D6F-9020-0C41817AD9D5 Q35962045-51B515CE-3452-4F18-9834-F74784417BBD Q36015358-2E0C9D68-8A04-4B29-9200-F94CB7524638 Q36071888-69FAD130-BCCC-4110-80AD-C6130AE0F4F5 Q36555565-C4A1ADFB-EE15-4270-AFDF-CB6D205FA34D Q36559641-7C4196FF-FF36-46A6-A60B-F1E2E6841DE1 Q36669409-BEBCE9C5-589E-4C20-B6C4-FB56212F3D89 Q36692520-DD40A851-E449-4E5B-8688-6C353F346171 Q37137850-661C4057-777C-45E5-A851-9193EBD4D7CA Q37193073-D4FD9707-E6A7-40B7-8F0F-EF11E0A8AA16 Q37853578-4C0C3D59-8B38-4EC6-9518-E4FB8430A424 Q38602638-1B49D40B-C44E-42CB-9182-C99500B82902 Q41861472-A07A4DA7-08EA-4620-BDAF-F5F4803BE8E0 Q47261963-14CCE1EA-7FBC-4B99-81F1-F4EC63A0BAA8 Q47417821-AF2921F2-9F75-4E53-89CC-D490269C0A6F

P2860

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

http://www.wikidata.org/entity/Q33472881

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

@ast

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

@en

type

label

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

@ast

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

@en

prefLabel

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

@ast

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

@en

P1433

Q33472881-84A0FF39-F482-4D7F-8F29-621B977A273F

P1476

Q33472881-93787EED-E96A-45E0-8CA8-6E453042165A

P2093

Q33472881-3FDA7969-B814-4EF1-BD90-90E2C3E728B7

Q33472881-5962F7BE-D574-48CB-B003-90E0B940412A

Q33472881-78CF341B-9794-44AB-A016-3DD69B6479C3

Q33472881-C147540B-7C44-4261-B869-D37FA0CB5F1D

Q33472881-C95EB202-39C1-4BF3-9DBC-A87F04D4C35A

Q33472881-EFE7188A-F34C-4E25-B48D-FB0DB97D5AE9

P2860

Q33472881-0C7A9328-5968-47D3-BC2B-B3E32C8DEA39

Q33472881-12A86A8E-2DFC-4294-9922-8B07A2F35379

Q33472881-15F0D6E7-1E40-4F9E-979E-5E6A4EDD1AFD

Q33472881-1C7375CF-2F4B-401E-AA10-19BB6A275E07

Q33472881-21335B3D-1A21-4536-B22E-A4A3C380ACB6

Q33472881-28D3D544-8554-401C-9ED0-77799175F35E

Q33472881-31167826-028C-4143-9ACA-186F5AF9B724

Q33472881-3B5A9B2B-BFBE-4F2E-A080-CF4229074A01

Q33472881-3CC52C98-D689-4CE4-AB27-E79441DB2F30

Q33472881-4279191A-4F83-4EA5-B9C5-2FB34447E928

P304

Q33472881-35164026-B31C-47C5-909A-04CF78531D68

P31

Q33472881-4E91C3C6-5943-4823-BEFE-1032C3CD28BA

P356

Q33472881-84504624-E342-4B28-800C-5603A65A2D96

P433

Q33472881-625F319D-F175-489B-A525-32D88CBA83C8

P478

Q33472881-73B77C01-C78A-4E3C-858C-53F49CA318D9

P50

Q33472881-B02E54D7-DC7B-4F5C-A923-A6CFA5F5AFF1

P577

Q33472881-C277A61A-2C27-49C0-BE2B-E3EA38B91649

P5875

Q33472881-041025B5-50BB-4A8E-9332-B5FB444C5B13

P698

Q33472881-BDD2FCD3-253C-48DD-8130-BE41B778C036

P921

Q33472881-6FFB3A80-D60E-440A-95FC-2DA2F46C421E

P932

Q33472881-F942873C-3513-44CD-830F-1F8E7348E602

P356

P1433

Assay and Drug Development Technologies

P1476

A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

@en

P2093

Douglas S Auld

http://www.w3.org/2001/XMLSchema#string

James Inglese

http://www.w3.org/2001/XMLSchema#string

King-Leung Fung

http://www.w3.org/2001/XMLSchema#string

Kyle R Brimacombe

http://www.w3.org/2001/XMLSchema#string

Matthew D Hall

http://www.w3.org/2001/XMLSchema#string

Michael M Gottesman

http://www.w3.org/2001/XMLSchema#string

P2860

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

Multidrug resistance in cancer: role of ATP-dependent transporters

The NCI60 human tumour cell line anticancer drug screen

Targeting multidrug resistance in cancer

Nanoliter dispensing for uHTS using pin tools.

Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site.

Development of a coculture system and use of confocal laser fluorescent microscopy to study human microvascular endothelial cell and mural cell interaction.

Application of laser-scanning fluorescence microplate cytometry in high content screening.

Plasma membrane calcium ATPase (PMCA4): a housekeeper for RT-PCR relative quantification of polytopic membrane proteins.

Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate format.

P304

233-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ADT.2008.165

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Christopher P Austin

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26313298

http://www.w3.org/2001/XMLSchema#string

P698

19548831

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

2814070

http://www.w3.org/2001/XMLSchema#string